Endpoints News May 14, 2026 BeOne’s next-gen BCL2 inhibitor wins FDA approval, taking aim at Venclexta
Endpoints News May 13, 2026 After an apparent cure, a gene editing company struggles to repeat the magic
Endpoints News May 13, 2026 Merck KGaA's clients are stockpiling due to Iran war, supporting guidance boost
Endpoints News May 12, 2026 Lilly points to low-dose Zepbound and Foundayo as weight loss maintenance options